Journal of Hepatology and Gastrointestinal disorders
Open Access

Department of Internal Medicine, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India

Publications

• Research Article   
  Hepatitis C and its Outcome in Patients of Malignancy Receiving Chemotherapy in Comparison to Non-Malignant Patients
  Author(s): Dawood Banday, Ashaq Hussain Parrey* and Bilal Rather
  
  Introduction: Hepatitis C Virus (HCV) is an RNA virus that belongs to the family of flaviviruses. Chronic hepatitis C infection is a very common disease globally affecting over 180 million people. It is a leading cause of chronic hepatitis, cirrhosis, and liver cancer and a primary indication for liver transplantation. As we move to the new era of oral antivirals as the treatment of hepatitis C we needed to see their efficacy and safety in patients with hepatitis C and underlying malignancy compared to the patients with hepatitis C without malignancy. Patients with malignancy with hepatitis C respond equally to the treatment of hepatitis C as patients without malignancy Aims and objectives: The aim of the study was to find the outcome of treatment in patients with hepatitis C with malignancy receiving Chemotherapy in comparison to non-malign.. View More»
  DOI: 10.35248/2475-3181.8.22.202

  Abstract HTML PDF